Crowley Wealth Management »

Dianthus Therapeutics shares owned by Crowley Wealth Management

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Crowley Wealth Management from 13F filings

Historical chart of Crowley Wealth Management investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Crowley Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Crowley Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.7k 221 39.35
2025-06-30 $4.1k 221 18.63
2025-03-31 $4.0k 221 18.14
2024-12-31 $4.8k 221 21.80

More positions owned by Crowley Wealth Management

Apple Common Stock (AAPL)
Tesla Common Stock (TSLA)
Proshares Ultra Qqq Etf Uit Exchange Traded (QLD)
Abbvie Common Stock (ABBV)
Lowes Cos Common Stock (LOW)
Proshares Ultra S&p 500 Etf Uit Exchange Traded (SSO)
Microsoft Corp Common Stock (MSFT)
Jpmorgan Chase & Co Common Stock (JPM)
Home Depot Common Stock (HD)
Proshares Ultra Russell 2000 Etf Uit Exchange Traded (UWM)
Disney Walt Common Stock (DIS)
Amgen Common Stock (AMGN)
Stryker Corp Common Stock (SYK)
Amazon.com Common Stock (AMZN)
Abbott Labs Common Stock (ABT)

View all positions for Crowley Wealth Management

Top funds holding Dianthus Therapeutics

FMR
Fairmount Funds Management
Avidity Partners Management
RA Capital Management
Wellington Management Company
Octagon Capital Advisors
Point72 Asset Management
TCG Crossover Management
Vanguard Group
BlackRock
Bain Capital Life Sciences Investors
Vestal Point Capital
Citadel Advisors
VR Adviser
Alliancebernstein

View all funds holding Dianthus Therapeutics